Belford, NJ, United States of America

Sherry A Shapiro

This inventor holds 2 USPTO granted patents. Top assignee: Schering Corporation. Active years: 2006-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sherry A Shapiro. Retrieved from https://idiyas.com/inventor/sherry-a-shapiro

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Mind of Sherry A Shapiro: Pioneering Solutions for Obesity Treatment

Introduction:

Sherry A Shapiro, a remarkable inventor hailing from Belford, NJ in the US, has made significant contributions in the realm of healthcare innovation. With a keen focus on developing solutions for obesity and related metabolic disorders, Shapiro's inventive spirit shines through his patented creations.

Latest Patents:

Shapiro's latest patents revolve around the development of MCH antagonists for the treatment of obesity. These groundbreaking inventions aim to address not only obesity but also metabolic disorders, eating disorders such as hyperphagia, and diabetes. The compounds he has devised demonstrate promising potential in combating these prevalent health issues.

Career Highlights:

Currently associated with Schering Corporation, Shapiro channels his inventive prowess towards pioneering advancements in the field of pharmaceuticals. His dedication to research and development is evident in the impactful solutions he continues to introduce to the healthcare landscape.

Collaborations:

In his professional journey, Shapiro has collaborated with esteemed colleagues such as Anandan Palani and Mark D McBriar. Together, they have synergized their expertise to drive innovation and bring forth cutting-edge pharmaceutical compositions aimed at improving patient outcomes.

Conclusion:

Sherry A Shapiro's inventive endeavors in developing MCH antagonists for the treatment of obesity stand as a testament to his commitment to addressing critical healthcare challenges. Through his persistent dedication and collaborative efforts, Shapiro exemplifies the spirit of innovation that propels advancements in the healthcare industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…